Bleakley Financial Group, LLC Apellis Pharmaceuticals, Inc. Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 73,505 shares of APLS stock, worth $2.09 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
73,505
Previous 78,956
6.9%
Holding current value
$2.09 Million
Previous $2.28 Billion
3.01%
% of portfolio
0.07%
Previous 0.07%
Shares
9 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$347 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$338 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$335 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$285 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$273 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.12B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...